1,2,3,4-tetrahydroquinoline 2,3,4-trione-3 or 4-oximes

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546146, 546148, C07D21522, C07D21538, C07D21544, C07D21546

Patent

active

056523688

ABSTRACT:
Disclosed herein are substituted or unsubstituted 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes or pharmaceutically acceptable salts thereof that have high binding to the glycine receptor and are usefully administered to animals for the treatment or prevention of the adverse consequences of the hyperactivity of the excitatory amino acids, or neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, for the treatment of anxiety, chronic pain, convulsions, and neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease and Down's syndrome; and for the inducement of anesthesia.

REFERENCES:
patent: 2726920 (1955-12-01), Federkeil et al.
patent: 4031099 (1977-06-01), Buckle
patent: 4065457 (1977-12-01), Buckle
patent: 4710508 (1987-12-01), Bergmeier et al.
patent: 5179107 (1993-01-01), Afonso et al.
patent: 5182258 (1993-01-01), Chiou et al.
patent: 5190956 (1993-03-01), Afonso
patent: 5198461 (1993-03-01), Watjen et al.
patent: 5234956 (1993-08-01), Lipton
patent: 5252584 (1993-10-01), Carling et al.
patent: 5268378 (1993-12-01), Baker et al.
patent: 5475007 (1995-12-01), Cai et al.
Fadda, Pharmazie, 46(10), pp. 743-744, 1991, abstract 116:173980.
Fadda, J Indian Chem Soc, 68(7), pp. 393-395, 1991, abstract 116:151524.
Mohamed, Indian J of Heterocyclic Chem, vol. 3, Oct-Dec 1993, pp. 69-80, 1993.
Boast, C. A. et al., "The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils," Brain Res. 442:345-348 (1988).
Brady, K. T. et. al., "Stereoisomers of N-Allylnormetazocine: Phencyclidine-Like Behavioral Effects in Squirrel Monkeys and Rats," Science 215:178-180 (1982).
Dahn, von H. and A. Donzel, "Uber die 1,2-Verschiebung der Saureamidgruppe bei der Benzilsaureumlagerung von Chinisatin," Helvetica Chimica Acta 50(7):1911-1917 (1967).
Dickenson, A. H. and E. Aydar, "Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat," Neurosci. Lett. 121:263-266 (1991).
Fadda, A. A. et al., "Synthesis of certain sulfonamides and aminopyranoquinoline derivatives from 4-hydroxyquinoline with biological interest," Chem. Abstr. 116:173980m (Jun. 1992).
Haley, J. E. et al., "Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat," Brain Res. 518:218-226 (1990).
Johnson, J. W. and P. Ascher, "Glycine potentiates the NMDA response in cultured mouse brain neurons," Nature 325:529-531 (1987).
Kemp, J. A. et al. "7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex," Proc. Natl. Acad. Sci. USA 85:6547-6550 (1988).
Koek, W. et al., "MK-801, a Proposed Noncompetitive Antagonist of Excitatory Amino Acid Neurotransmission, Produces Phencyclidine-Like Behavioral Effects in Pigeons, Rats and Rhesus Monkeys," J. Pharmacol. Exp. Ther. 245(3):969-974 (1988).
Leeson, P. D. et al., "Kynurenic Acid Derivatives. Structure-Activity Relationships for Excitatory Amino Acid Antagonism and Identification of Potent and Selective Antagonists at the Glycine Site on the N-Methyl-D-aspartate Receptor," J. Med. Chem. 34(4):1243-1252 (1991).
Masoud, M. S. et al., "Studies on Osmium-Quinisatine Oxime Reaction," Revue Roumaine de Chimie 26(7):961-965 (1981).
Patel, G. H. and C. M. Mehta, "Synthesis of 2,4-Dihydroxyquinolines Using Polyphosphoric Acid as the Cyclizing Agent," J. Sci. Instr. Res. 19B:436-438 (1960).
Prisyazhnyuk, P. V. et al., "Synthesis and antimicrobial properties of some quinoline derivatives," Chem. Abstr. 101:171042y (1984).
Schoepp, D. D. et al., "Neuroprotectant effects of LY 274614, a structurally novel systematically active competitive NMDA receptor antagonist," J. Neural. Trans. 85:131-143 (1991).
Skilling, S. R. et al., "Differential Effects of C- and N-Terminal Substance P Metabolites on the Release of Amino Acid Neurotransmitters from the Spinal Cord: Potential Role in Nociception," J. Neurosci. 10(4):1309-1318 (1990).
Stankevicius, A. et al., "Comparative mass-spectometric behavior of o-hydroxynitroso derivatives in the quinoline, isoquinoline and coumarin series," Chem. Abstr. 122:138465t (1990).
Tricklebank, M.D. et al., "A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine," Eur. J. Pharmacol. 141:497-501 (1987).
Tricklebank, M.D. et al., "The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor," Eur. J. Pharmacol. 167:127-135 (1989).
Wheeler, T. N. and J. Meinwald, "Formation and Photochemical Wolff Rearrangement of Cyclic .alpha.-Diazo Ketones: D-Norandrost-5-en-3.beta.-ol-16-carboxylic Acids," Org. Syn. Coll. 6:840-844 (1988).
Willetts, J. and R. L. Balster, "The Discriminative Stimulus Effects of N-methyl-D-aspartate Antagonists in phencyclidine-Trained Rats," Neuropharmacol. 27(12): 1249-1256 (1988).
Zukin, S. R. et al., "Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors," Brain Res. 294:174-177 (1984).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1,2,3,4-tetrahydroquinoline 2,3,4-trione-3 or 4-oximes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,2,3,4-tetrahydroquinoline 2,3,4-trione-3 or 4-oximes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,3,4-tetrahydroquinoline 2,3,4-trione-3 or 4-oximes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-634851

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.